# Marker Therapeutics, Inc.: Form DEF 14A, filed Feb 4, 2025

- Company: [Marker Therapeutics, Inc.](/companies/mrkr.md) (CIK 1094038)
- Form: DEF 14A
- Filed: 2025-02-04
- Accepted by EDGAR: Feb 4, 2025, 21:05 ET
- Period: 2025-03-21
- Accession: 0001104659-25-009098
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1094038/000110465925009098/tm253006-2_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1094038/000110465925009098/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1094038/000110465925009098/tm253006-2_def14a.htm

Filed Feb 4, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-009098. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.